ArticleEFSA journal. European Food Safety Authority2024
Statement on the confirmatory data following the Article 12 MRL review for triclopyr.
Article in EFSA journal. European Food Safety Authority, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In accordance with Article 31 of Regulation (EC) No 178/2002, EFSA received a mandate from the European Commission to issue a scientific statement concerning the confirmatory data following the review of the existing maximum residue levels (MRLs) under Article 12 of Regulation (EC) No 396/2005 for triclopyr. Although the required application in support to the confirmatory data following the MRL review was not submitted within deadline, some information identified as unavailable in the MRL review has been made available to EFSA in the context of other applications submitted under different regulatory processes. Based on the assessment of the available data, EFSA concluded that the tentative MRL for apples, pears and peaches is confirmed. The tentative MRLs for grapefruits, oranges, lemons, mandarins, apricots and rice are not fully supported by data. Risk manager may consider the alternative MRL of 0.07 mg/kg for oranges, lemons, mandarins and the lowering to the specific limit of quantification (LOQ) for grapefruits, apricots and rice. An update of the consumer risk assessment for triclopyr was performed and it did not indicate any potential consumer health risks. The statement was circulated to Member States for consultation via a written procedure before finalisation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.